Anti-Murine IL-6 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 500-P56 Descripcion Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure recombinant Murine IL-6. Anti-Murine IL-6 specific antibody was purified by affinity chromatography employing immobilized Murine IL-6 matrix. Immunogen: E.coli derived Recombinant Murine IL-6 (PeproTech catalog# 216-16) Sandwich ELISA: To detect Murine IL-6 by sandwich ELISA (using 100μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Murine IL-6 (500-P56Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Murine IL-6. Western Blot: To detect Murine IL-6 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Murine IL-6 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Mouse, Mouse + Bacteria References SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest COVID-19 Angiogenesis/Cardiovascular Cancer Cell Culture Diabetes/Weight Regulation Immune System Inflammation Neurobiology Stem Cells & Differentiation Wound Healing Allergy Transplantation product.subtitle.recentcitations Primer autor Klooster, J P Titulo Enterocytes, fibroblasts and myeloid cells synergize in anti-bacterial and anti-viral pathways with IL22 as the central cytokine Citar Communications Biology; 4(1) pg631 PudMed id 34045640 Primer autor Choi, S Titulo Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4 Citar Journal of immunology (Baltimore, Md. : 1950); 200(9) pg3087-3099 PudMed id 29563177 Primer autor Scarlett, U K Titulo Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. Citar The Journal of Experimental Medicine; 209(3) pg495-506 PudMed id 22351930